NurseAdemy | Maternity • Clinical Judgment & NGN Preparation
This guide reviews the clinical concepts you should understand before completing the Maternity II workbook. It is designed to strengthen pattern recognition, prioritization, and safe decision-making.
It does not provide the answers to the workbook and does not repeat the exact clinical scenarios. Use it to prepare your reasoning, not to memorize isolated facts.
Different obstetric emergencies may initially present with similar maternal or fetal findings. Before deciding what to do, determine whether the immediate threat is maternal, fetal, or both.
The newborn should be evaluated as a complete physiologic transition, not as a collection of isolated vital signs.
| Assessment Area | Expected Focus | When to Reassess or Intervene |
|---|---|---|
| Color | Differentiate peripheral color changes from central cyanosis. | Persistent central color change or poor perfusion requires prompt evaluation. |
| Respirations | Observe rate, effort, grunting, flaring, and retractions. | Abnormal effort is often more important than the respiratory rate alone. |
| Temperature | Evaluate response to warming and skin-to-skin care. | Persistent hypothermia increases oxygen and glucose consumption. |
| Feeding and Reflexes | Assess suck, rooting, Moro, tone, and symmetry. | Weak feeding, asymmetry, or decreased tone may indicate illness or neurologic compromise. |
| Size for Gestational Age | Recognize LGA and SGA as risk categories. | Risk status changes which complications should be monitored after birth. |
Maternal glucose control affects fetal growth and the newborn’s metabolic transition after birth.
When evaluating respiratory distress, identify why the newborn is hypoxic before selecting an intervention.
| Clinical Clue | What to Analyze | Why It Matters |
|---|---|---|
| Gestational age | Preterm, early term, or post-term? | Different disorders are associated with different maturity levels. |
| Mode of delivery | Was labor present? Was delivery by scheduled cesarean birth? | Absence of labor may delay fetal lung fluid clearance. |
| Amniotic fluid | Was meconium present? | Meconium exposure changes the likely respiratory disorder. |
| Breath sounds and effort | Clear, coarse, diminished, grunting, flaring, or retracting? | Helps distinguish retained fluid, surfactant deficiency, aspiration, or infection. |
| Chest x-ray | Fluid pattern, diffuse opacity, patchy infiltrates, or focal changes? | Imaging supports the clinical pattern. |
Postpartum hemorrhage is recognized by the complete maternal assessment rather than estimated blood loss alone.
| Assessment | Clinical Question |
|---|---|
| Fundus | Is it boggy, firm, elevated, or displaced? |
| Bladder | Could distention be preventing effective uterine contraction? |
| Bleeding | Is it heavy, continuous, clotting, or inconsistent with uterine tone? |
| Perfusion | Are hypotension, tachycardia, pallor, cool skin, or altered mentation present? |
The postpartum client may appear stable while developing infection, thromboembolism, urinary retention, or a severe mood disorder.
| Clinical Pattern | What Makes It Concerning |
|---|---|
| Fever with uterine tenderness and foul-smelling lochia | Suggests uterine infection and requires prompt treatment. |
| Unilateral calf swelling, warmth, and tenderness | Raises concern for deep vein thrombosis. |
| Large postvoid residual or inability to empty the bladder | May increase pain, uterine displacement, and hemorrhage risk. |
| Localized breast pain with systemic symptoms | May indicate mastitis and requires follow-up. |
| Hopelessness, inability to sleep, intrusive thoughts, or thoughts of harm | Requires immediate safety assessment and escalation. |
Preventive newborn care is designed to reduce immediate and long-term complications before discharge.
| Intervention | Purpose | Teaching Focus |
|---|---|---|
| Vitamin K | Supports normal clotting and reduces bleeding risk. | Explain why newborns are vulnerable to deficiency after birth. |
| Erythromycin ophthalmic ointment | Reduces the risk of specific neonatal eye infections. | Clarify that it is preventive and may temporarily blur vision. |
| Hepatitis B vaccine | Begins active immunization against hepatitis B. | Explain timing and the need for future doses. |
| Newborn screening | Identifies selected disorders before symptoms appear. | Explain timing, follow-up, and why abnormal results require confirmation. |
Different maternal infections require different strategies to protect the fetus, the newborn, or both.
| Clinical Area | During Labor | After Birth |
|---|---|---|
| GBS | Assess need and timing for intrapartum antibiotic prophylaxis. | Monitor the newborn based on exposure and adequacy of prophylaxis. |
| HIV | Continue prescribed therapy and minimize unnecessary invasive procedures. | Follow the newborn prophylaxis and feeding plan. |
| Hepatitis B | Identify maternal surface antigen status before delivery. | Ensure timely newborn immunization and immune prophylaxis when indicated. |
| Rubella and TORCH exposures | Assess immunity, exposure history, gestational age, and fetal risk. | Provide appropriate testing, teaching, and follow-up. |
Always evaluate the client’s diagnosis, current condition, and medical history before administering obstetric medications.
| Medication Group | Therapeutic Goal | Safety Question |
|---|---|---|
| Oxytocin | Promote uterine contraction or treat uterine atony. | Is uterine activity excessive, or is fetal status deteriorating? |
| Magnesium sulfate | Prevent seizures or provide fetal neuroprotection in selected cases. | Are respirations, reflexes, urine output, and serum levels safe? |
| Terbutaline and nifedipine | Temporarily reduce uterine activity. | Are maternal heart rate, blood pressure, and contraindications acceptable? |
| Carboprost and methylergonovine | Increase uterine tone during postpartum hemorrhage. | Does the client have a medical history that makes the medication unsafe? |
| Misoprostol and TXA | Support hemorrhage management through uterine contraction or clot stabilization. | Is the medication appropriate for the cause and timing of bleeding? |
| Clinical Presentation | Ask Yourself |
|---|---|
| Sudden fetal or maternal deterioration during labor | What happened immediately before the change, and who is in the greatest danger? |
| Newborn with several mildly abnormal findings | Do the findings form a pattern of respiratory, metabolic, thermal, or neurologic compromise? |
| Infant of a mother with gestational diabetes | Is this a risk factor only, or is the newborn actively symptomatic? |
| Newborn respiratory distress | What do gestational age, delivery history, breath sounds, oxygen needs, and imaging suggest? |
| Postpartum bleeding | Which of the 4 Ts best explains the pattern, and what action reduces harm first? |
| Postpartum fever, calf pain, urinary retention, or mood changes | Which finding threatens life, perfusion, infection control, or safety? |
| Newborn preventive care | Can the parents explain the purpose, timing, and follow-up? |
| Maternal infection | Which intervention is most time-sensitive for maternal or newborn protection? |
| Obstetric medication order | What assessment, vital sign, or medical history could make the medication unsafe? |